Dexelvucitabine
Dexelvucitabine is a failed experimental agent for the management of HIV infection. Dexelvucitabine is a cytidine nucleoside analog and nucleoside reverse transcriptase inhibitor. It was found to inhibit HIV-1 replication in vitro and during Phase II clinical trials, it was found to decrease mean viral load in patients with HIV.
primaryTopic
Dexelvucitabine
Dexelvucitabine is a failed experimental agent for the management of HIV infection. Dexelvucitabine is a cytidine nucleoside analog and nucleoside reverse transcriptase inhibitor. It was found to inhibit HIV-1 replication in vitro and during Phase II clinical trials, it was found to decrease mean viral load in patients with HIV.
has abstract
Dexelvucitabine is a failed ex ...... , lipase) in a phase II trial.
@en
IUPAC name
4-Amino-5-fluoro-1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]pyrimidin-2-one
@en
thumbnail
Wikipage page ID
21,632,373
Wikipage revision ID
692,993,785
othernames
Verifiedfields
verifiedrevid
444,914,527
Watchedfields
subject
hypernym
comment
Dexelvucitabine is a failed ex ...... ral load in patients with HIV.
@en
label
Dexelvucitabine
@en
